516 related articles for article (PubMed ID: 21493124)
1. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
[TBL] [Abstract][Full Text] [Related]
2. The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours.
Cankar K; Finderle Z; Jan J
Caries Res; 2011; 45(2):136-41. PubMed ID: 21447949
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-level laser therapy on radiotherapy-induced hyposalivation and xerostomia: a pilot study.
Saleh J; Figueiredo MA; Cherubini K; Braga-Filho A; Salum FG
Photomed Laser Surg; 2014 Oct; 32(10):546-52. PubMed ID: 25302460
[TBL] [Abstract][Full Text] [Related]
6. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
8. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
[TBL] [Abstract][Full Text] [Related]
9. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study.
Lakshman AR; Babu GS; Rao S
J Cancer Res Ther; 2015; 11(1):229-33. PubMed ID: 25879367
[TBL] [Abstract][Full Text] [Related]
11. Salivary status in patients treated for head and neck cancer.
Dawes C; Odlum O
J Can Dent Assoc; 2004 Jun; 70(6):397-400. PubMed ID: 15175120
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
13. The role of hyperbaric oxygen therapy in the prevention and management of radiation-induced complications of the head and neck - a systematic review of literature.
Ravi P; Vaishnavi D; Gnanam A; Krishnakumar Raja VB
J Stomatol Oral Maxillofac Surg; 2017 Dec; 118(6):359-362. PubMed ID: 28838774
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients.
Kakoei S; Haghdoost AA; Rad M; Mohammadalizadeh S; Pourdamghan N; Nakhaei M; Bahador M
Arch Iran Med; 2012 Apr; 15(4):214-8. PubMed ID: 22424038
[TBL] [Abstract][Full Text] [Related]
15. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
16. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
Jen YM; Lin YC; Wang YB; Wu DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):322-7. PubMed ID: 16504865
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation therapy and xerostomia.
Chambers MS; Weber RS; Garden AS
J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
[TBL] [Abstract][Full Text] [Related]
18. Hypnosis for postradiation xerostomia in head and neck cancer patients: a pilot study.
Schiff E; Mogilner JG; Sella E; Doweck I; Hershko O; Ben-Arye E; Yarom N
J Pain Symptom Manage; 2009 Jun; 37(6):1086-1092.e1. PubMed ID: 19186028
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
